InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,792.80
(
0.00%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.31
(
-0.34%
)
Bitcoin
62,875.04
(
3.45%
)
Post# of 3647
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

johnnymcgriffin347

Send PM Follow Ignore
Followers 0
Posts 541
Boards Moderated 0
Alias Born 11/13/2018

johnnymcgriffin347

Re: None

Thursday, 04/22/2021 11:14:11 PM

Thursday, April 22, 2021 11:14:11 PM

Post# of 3647
Where will CVBT get their catheters???

Zhittya Genesis Medicine has announced that they are now developing their own catheters for their future clinical trials. Such an innovation would likely give Zhittya Genesis Medicine a cutting edge over CVBT/Venturis Therapeutics, which has yet to even produce the FGF-1 molecule, already putting CVBT behind Zhittya Genesis Medicine by about 1-2 years.

If CVBT/Venturis Therapeutics makes the molecule and restarts the clinical trials after nearly a decade of inactivity, will we have to buy our catheters from Zhittya Genesis Medicine? If we have to buy our catheters from them how will that affect CVBT's strategy in the future?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up